BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2843076)

  • 1. Reduction of monocyte 5'nucleotidase activity by gamma-interferon in multiple sclerosis and autoimmune diseases.
    Armstrong MA; Shah S; Hawkins SA; Bell AL; Roberts SD
    Ann Neurol; 1988 Jul; 24(1):12-6. PubMed ID: 2843076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ecto-5'nucleotidase activity in B and T lymphocytes and monocytes of patients with multiple sclerosis.
    Armstrong MA; Haire M
    Ann Neurol; 1986 Jan; 19(1):94-6. PubMed ID: 3004321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Class II major histocompatibility complex antigen expression on unstimulated and gamma-interferon stimulated monocytes from patients with multiple sclerosis, rheumatoid arthritis and normal controls.
    Armstrong MA; Crockard AD; Hawkins SA; Gamble LA; Shah S; Bell AL
    Autoimmunity; 1991; 9(3):261-8. PubMed ID: 1777559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell lymphokine-induced secretion of cytokines by monocytes from patients with multiple sclerosis.
    Maimone D; Reder AT; Gregory S
    Cell Immunol; 1993 Jan; 146(1):96-106. PubMed ID: 8425234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-gamma treatment increases HLA-DR expression on monocytes in severely injured patients.
    Hershman MJ; Appel SH; Wellhausen SR; Sonnenfeld G; Polk HC
    Clin Exp Immunol; 1989 Jul; 77(1):67-70. PubMed ID: 2504520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of monocyte activation in patients with rheumatoid arthritis by leukapheresis therapy.
    Hahn G; Stuhlmüller B; Hain N; Kalden JR; Pfizenmaier K; Burmester GR
    J Clin Invest; 1993 Mar; 91(3):862-70. PubMed ID: 8450066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-beta up-regulates the expression of co-stimulatory molecules CD80, CD86 and CD40 on monocytes: significance for treatment of multiple sclerosis.
    Marckmann S; Wiesemann E; Hilse R; Trebst C; Stangel M; Windhagen A
    Clin Exp Immunol; 2004 Dec; 138(3):499-506. PubMed ID: 15544628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.
    Mitsdoerffer M; Schreiner B; Kieseier BC; Neuhaus O; Dichgans J; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2005 Feb; 159(1-2):155-64. PubMed ID: 15652415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analyses of immunosenescent markers in patients with autoimmune disease.
    Thewissen M; Somers V; Venken K; Linsen L; van Paassen P; Geusens P; Damoiseaux J; Stinissen P
    Clin Immunol; 2007 May; 123(2):209-18. PubMed ID: 17317320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonistic action of IFN-beta and IFN-gamma on high affinity Fc gamma receptor expression in healthy controls and multiple sclerosis patients.
    Van Weyenbergh J; Lipinski P; Abadie A; Chabas D; Blank U; Liblau R; Wietzerbin J
    J Immunol; 1998 Aug; 161(3):1568-74. PubMed ID: 9686625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired hypothalamic-pituitary-adrenal axis activity in patients with multiple sclerosis.
    Ysrraelit MC; Gaitán MI; Lopez AS; Correale J
    Neurology; 2008 Dec; 71(24):1948-54. PubMed ID: 19064876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monocyte activation after open and laparoscopic surgery.
    Klava A; Windsor A; Boylston AW; Reynolds JV; Ramsden CW; Guillou PJ
    Br J Surg; 1997 Aug; 84(8):1152-6. PubMed ID: 9278666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokines in chronic inflammatory arthritis. III. Rheumatoid arthritis monocytes are not unusually sensitive to gamma-interferon, but have defective gamma-interferon-mediated HLA-DQ and HLA-DR induction.
    Bergroth V; Zvaifler NJ; Firestein GS
    Arthritis Rheum; 1989 Sep; 32(9):1074-9. PubMed ID: 2505778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFN-beta regulates CD73 and adenosine expression at the blood-brain barrier.
    Niemelä J; Ifergan I; Yegutkin GG; Jalkanen S; Prat A; Airas L
    Eur J Immunol; 2008 Oct; 38(10):2718-26. PubMed ID: 18825744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCR3, CCR5, interleukin 4, and interferon-gamma expression on synovial and peripheral T cells and monocytes in patients with rheumatoid arthritis.
    Nissinen R; Leirisalo-Repo M; Tiittanen M; Julkunen H; Hirvonen H; Palosuo T; Vaarala O
    J Rheumatol; 2003 Sep; 30(9):1928-34. PubMed ID: 12966592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release of lymphokines after infection with Epstein Barr virus in vitro. II. A monocyte-dependent inhibitor of interleukin 1 downregulates the production of interleukin 2 and interferon-gamma in rheumatoid arthritis.
    Lotz M; Tsoukas CD; Fong S; Dinarello CA; Carson DA; Vaughan JH
    J Immunol; 1986 May; 136(10):3643-8. PubMed ID: 3009609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. beta-Adrenergic receptor density and function of peripheral blood mononuclear cells are increased in multiple sclerosis: a regulatory role for cortisol and interleukin-1.
    Zoukos Y; Leonard JP; Thomaides T; Thompson AJ; Cuzner ML
    Ann Neurol; 1992 Jun; 31(6):657-62. PubMed ID: 1325138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigens in human monocytes. III. Use of monocytes in typing for HLA-D related (DR) antigens.
    Colbaugh P; Stastny P
    Transplant Proc; 1978 Dec; 10(4):871-4. PubMed ID: 310596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
    Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
    Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.